Impact of neoadjuvant chemotherapy on Ki-67 and PCNA labeling indices for esophageal squamous cell carcinomas

International Journal of Radiation Oncology Biology Physics

Volumn 49, Issue 2, 2001, Pages 527-532

  Horii, Naotoshi ^a   Nishimura, Yasumasa ^b   Okuno, Yoshishige ^a   Kanamori, Shuichi ^b   Hiraoka, Masahiro ^a   Shimada, Yutaka ^a   Imamura, Masayuki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Esophageal cancer; Ki 67; Neoadjuvant chemotherapy; PCNA; Quiescent cells

Indexed keywords

CISPLATIN; CYCLINE; KI 67 ANTIGEN;

ADULT; AGED; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ESOPHAGUS BIOPSY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA;

AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHEMOTHERAPY, ADJUVANT; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0035253820     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)01468-1     Document Type: Conference Paper

References (29)

1. The assessment of cellular proliferation by immunohistochemistry; A review of currently available methods and their applications
2. Update on proliferation-associated antibodies applicable to formalin- fixed paraffin-embedded tissue and their clinical applications
3. Evaluation of proliferation parameters in in vivo bromodeoxyuridine labelled lung cancers
4. Measurement of proliferation activities in human tumor models; A comparison of flow cytometric methods
5. Immunoreactivity of proliferating cell nuclear antigen compared with bromodeoxyuridine incorporation in normal and neoplastic rat tissue
6. Cell-cycle-related staining patterns of anti-proliferative cell nuclear antigen monoclonal antibodies; Comparison with BrdUrd labeling, and Ki-67 staining
7. Bleomycin/cis-platin as neoadjuvant chemotherapy before radical radiotherapy in localized, inoperable carcinoma of the esophagus. A prospective randomized multicentre study; the second Scandinavian trial in esophageal cancer
8. Neoadjuvant chemotherapy followed by radiotherapy should not be a standard approach for locally advanced cervical cancer
9. Treatment of cancer with radiation and drugs
10. Prognostic values of proliferating cell nuclear antigen (PCNA) and Ki-67 for radiotherapy of esophageal squamous cell carcinomas
11. Prognostic significance of the MIB-1 proliferation index for patients with squamous cell carcinoma of the esophagus
12. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma
13. Prognostic significance of proliferating cell nuclear antigen (PCNA) in squamous cell carcinoma of the esophagus
14. Markers of radioresistance in squamous cell carcinomas of the head and neck; A clinicopathologic and immunohistochemical study
15. Prognostic significance of the PC10 index as a prospective assay for cervical cancer treated with radiation therapy alone
16. Differential values of Ki-67 index and mitotic index of proliferating cell population; An assessment of cell cycle and prognosis in radiation therapy for cervical cancer
17. Correlation of cervical carcinoma c-erb B-2 oncogene with cell proliferation parameters in patients treated with radiation therapy for cervical carcinoma
18. Tumor proliferation in rectal cancer following preoperative irradiation
19. Acceleration of proliferative activity of esophageal squamous cell carcinoma with invasion beyond the mucosa; Immunohistochemical analysis of Ki-67 and p53 antigen in relation to histopathological findings
20. Chemotherapy followed by operation versus operation alone in the treatment of patients with localized esophageal cancer; A preliminary report of Intergroup study 113 (RTOG 89-11)
21. Neoadjuvant chemotherapy in operable esophageal squamous cell cancer; Final report of a phase III multicenter randomized controlled trial
22. Progress report of combined chemoradiotherapy versus radiotherapy alone in patients with esophageal cancer; An Intergroup study
23. A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer
24. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer; First analysis of a randomized trial in 353 patients
25. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588. Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
26. The radiosensitivity of quiescent cell populations in murine solid tumors in irradiation with fast neutrons
27. Distribution of hypoxia and proliferation associated markers in spontaneous canine tumors
28. Proliferation and hypoxia in human squamous cell carcinoma of the cervix; First report of combined immunohistochemical assays
29. The hazard of accelerated tumor clonogen repopulation during radiotherapy